Emily R. Cox, PhD

home / authors / emily-r-cox-phd

Articles

Site Logo
December 1st 2008

Lowering Copayments: Impact of Simvastatin Patent Expiration on Patient Adherence

Rebecca L. Sedjo, PhD Emily R. Cox, PhD

Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.

Site Logo
June 1st 2007

Relationship Between Generic and Preferred-brand Prescription Copayment Differentials and Generic Fill Rate

Douglas E. Mager, MA Emily R. Cox, PhD

Site Logo
July 1st 2004

Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy

Brenda R. Motheral, PhD Rochelle Henderson, MPA Emily R. Cox, PhD

Site Logo
December 1st 2003

Verification of a Decision Analytic Model Assumption Using Real-World Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

Emily R. Cox, PhD Brenda Motheral, PhD Doug Mager, BS

Site Logo
November 1st 2003

Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy

Emily R. Cox, PhD Brenda Motheral, PhD Mark Frisse, MD* Andrew Behm, PharmD Doug Mager, BS

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Alfred L. Garfall, MD, an expert on multiple myeloma
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo